| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.19 | 3e-06 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-06 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-06 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-06 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.15 | 4e-06 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.18 | 5e-06 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-06 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.16 | 7e-06 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.17 | 7e-06 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.16 | 7e-06 |